Skip to content

Clinical trials

Phase 4 Systemic Inflammatory Response Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20073
20101
20142
20153
20161
20171
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amsterdam UMC, location VUmc2
Ain Shams University1
Assiut University1
CAMC Health System1
Karolinska Institutet1
Kingman Regional Medical Center1
Ludwig-Maximilians - University of Munich1
Medical University of Vienna1
Ono Pharmaceutical Co., Ltd.1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome18
Sepsis4
Postoperative Pain2
Shock2
Shock, Septic2
Acute Lung Injury1
Adrenal Insufficiency1
Bacteremia1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.